Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial.
Jin Xiao LianSarah Morag McGheeChing SoAlfred Siu Kei KwongRita SumWendy Wing Sze TsuiDavid Vai Kiong ChaoJonathan Cheuk-Hung ChanPublished in: Journal of diabetes investigation (2021)
A screening fee of HK$150, representing approximately a half subsidy, appears to be as effective in maximizing uptake as a full subsidy (HK$0) and without deterring those at high risk of diabetic retinopathy from screening.